Diana Shipping criticizes Genco board's poison pill defense strategy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- US stocks set for lower open as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- Goldman Sachs to acquire real estate company LCN for up to $410M
Diana Shipping Inc. Addresses Genco Shipping & Trading’s Last-Ditch Attempt to Cling to Poison Pill
June 15, 2026 6:30 AM EDTAmid Growing Opposition from Shareholders, Genco Board Continues to Further Entrench Itself by Refusing to Rescind the Poison Pill Should Shareholders Vote Against the Poison Pill as Recommended by ISS
Genco Continues to Put Forth Manufactured Claims Regarding Dianas Disclosures to Distract Shareholders, Fails to Explain Why They Justify Instituting a Drastic Defensive Measure Against Largest Shareholder
Diana Urges Shareholders to Vote "AGAINST" Ratifying Genco's Poison Pill and Equity Incentive Plan
Also Urges Genco... More
